Safety and Acceptability of Q GRFT Nasal Spray for COVID-19 Prophylaxis

NCT05180500 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

COVID-19
Pharmacokinetics
Safety

Interventions

DRUG: Q-Griffithsin
DRUG: Placebo

Sponsor

Sharon Hillier

Collaborators

[object Object]